BiochemistryACS Chemical BiologyPeer-reviewed
Optimizing PDIA1 Inhibition as a Strategy to Inhibit NLRP3 Inflammasome Activation and Activity
Chavin Buasakdi, Caroline R. Stanton, Prerona Bora…·R. Luke Wiseman
This study identifies potent PDIA1 inhibitors that block NLRP3 inflammasome activity without significant cellular toxicity, offering a strategy to treat diseases involving hyperactive NLRP3.
DOI 10.1021/acschembio.5c00221